HCA Healthcare (HCA) Given a $105.00 Price Target by SunTrust Banks Analysts

SunTrust Banks set a $105.00 target price on HCA Healthcare (NYSE:HCA) in a report released on Thursday morning. The firm currently has a buy rating on the stock.

Several other equities research analysts also recently weighed in on HCA. Cantor Fitzgerald restated a buy rating and issued a $95.00 target price on shares of HCA Healthcare in a research note on Wednesday, September 6th. ValuEngine downgraded shares of HCA Healthcare from a buy rating to a hold rating in a research note on Thursday, September 7th. KeyCorp restated a buy rating and issued a $95.00 target price on shares of HCA Healthcare in a research note on Thursday, September 7th. Robert W. Baird restated a buy rating on shares of HCA Healthcare in a research note on Thursday, September 28th. Finally, Piper Jaffray Companies restated a buy rating and issued a $92.00 target price on shares of HCA Healthcare in a research note on Wednesday, October 4th. Two analysts have rated the stock with a sell rating, five have given a hold rating and nineteen have issued a buy rating to the company’s stock. HCA Healthcare presently has an average rating of Buy and an average target price of $90.95.

HCA Healthcare (NYSE HCA) traded up $1.39 during midday trading on Thursday, hitting $87.84. 1,957,400 shares of the stock were exchanged, compared to its average volume of 2,307,891. The company has a current ratio of 1.68, a quick ratio of 1.41 and a debt-to-equity ratio of -6.46. HCA Healthcare has a 1 year low of $71.18 and a 1 year high of $91.03. The company has a market capitalization of $30,607.84, a P/E ratio of 13.12, a PEG ratio of 1.27 and a beta of 0.56.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, October 31st. The company reported $1.21 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $1.21. The firm had revenue of $10.70 billion for the quarter, compared to the consensus estimate of $10.70 billion. HCA Healthcare had a net margin of 6.13% and a negative return on equity of 47.16%. The company’s quarterly revenue was up 4.1% on a year-over-year basis. During the same period last year, the firm earned $1.45 earnings per share. equities research analysts expect that HCA Healthcare will post 6.56 earnings per share for the current year.

In related news, SVP Victor L. Campbell sold 8,000 shares of the firm’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $75.82, for a total transaction of $606,560.00. Following the completion of the transaction, the senior vice president now owns 127,275 shares of the company’s stock, valued at $9,649,990.50. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the firm’s stock in a transaction on Wednesday, November 22nd. The stock was sold at an average price of $78.00, for a total transaction of $167,700.00. Following the transaction, the insider now directly owns 12,476 shares of the company’s stock, valued at approximately $973,128. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,700 shares of company stock valued at $1,773,872. 2.90% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Northwestern Mutual Wealth Management Co. increased its holdings in HCA Healthcare by 14.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after buying an additional 143 shares in the last quarter. Bronfman E.L. Rothschild L.P. increased its holdings in HCA Healthcare by 35.1% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after buying an additional 320 shares in the last quarter. Atlantic Trust LLC purchased a new position in HCA Healthcare in the second quarter valued at $118,000. Acrospire Investment Management LLC increased its holdings in HCA Healthcare by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after buying an additional 200 shares in the last quarter. Finally, BB&T Investment Services Inc. purchased a new position in HCA Healthcare in the second quarter valued at $141,000. 75.25% of the stock is owned by institutional investors.

WARNING: This news story was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://www.com-unik.info/2017/12/22/hca-healthcare-hca-given-a-105-00-price-target-by-suntrust-banks-analysts.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

What are top analysts saying about HCA Healthcare? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HCA Healthcare and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit